SBGBL
Multiple solid tumors (TNBC, prostate, oral, glioblastoma, hepatic, cervical, colon, lung)
PreclinicalActive
Key Facts
Indication
Multiple solid tumors (TNBC, prostate, oral, glioblastoma, hepatic, cervical, colon, lung)
Phase
Preclinical
Status
Active
Company
About Sathgen Therapeutics
Innovative plant‑derived oncology and antiviral drug developer with a Phase I lead candidate.
View full company profileOther Multiple solid tumors (TNBC, prostate, oral, glioblastoma, hepatic, cervical, colon, lung) Drugs
| Drug | Company | Phase |
|---|---|---|
| LSPGBL | Sathgen Therapeutics | Preclinical |